Boeing Co vs Nuwellis Inc — how do they compare? Boeing Co trades at $217.88 (market cap $169.89B), while Nuwellis Inc trades at $3.16 (market cap $1.02M). The key difference: Boeing Co is far larger — about 166558.8× Nuwellis Inc's market cap, and Boeing Co pays a 0.03% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| BA | NUWE | |
|---|---|---|
Market Cap | $169.89B | $1.02M |
Volume | 7,591,579 | — |
Sector | Industrials | Technology |
52-Week High | $252.15 | $558.26 |
52-Week Low | $179.12 | $2.80 |
Enterprise Value | $196.20B | -$789.97K |
Dividend Yield | 0.03% | — |
Signals from Pluang's Aura AI — not financial advice
Boeing (BA) trades at $215.51, down 3.05% on the day, amid a bearish technical signal. The stock shows mixed fundamentals with a high P/E of 85.18 but improving revenue and net income, reaching $89.46B and $2.24B in 2025, respectively. Recent news highlights potential order wins, including discussions with Riyadh Air for additional 787s, while technical indicators point to support near $209.
Outlook remains cautiously optimistic with a consensus price target of $268.33, implying 24.5% upside, but risks include volatile cash flows, high debt, and ongoing operational challenges. Analyst sentiment is bullish with 66.7% buy ratings, though investors should monitor execution on delivery targets and margin improvements.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
The Boeing Company, together with its subsidiaries, develops, produces, and markets commercial jet aircraft, as well as provides related support services to the commercial airline industry worldwide. The Company also researches, develops, produces, modifies, and supports information, space, and defense systems, including military aircraft, helicopters and space and missile systems.
Read more on BA →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →